Related Experiment Videos
[Cerebrospinal fluid in cerebrovascular disorders. Study of 1500 cases]
A Spina-França1, J A Livramento, L R Machado
1Departamento de Neurologia, Faculdade de Medicina, Universidade de São Paulo.
Insights
Cerebrospinal fluid (CSF) analysis in 1500 acute stroke patients revealed distinct patterns. CSF findings correlate with stroke type, systemic issues, and central nervous system lesions, aiding diagnosis.
Area of Science:
- Neurology
- Neurochemistry
- Clinical Diagnostics
Context:
- Acute stroke diagnosis and management.
- Analysis of cerebrospinal fluid (CSF) in neurological emergencies.
- Evaluation of 1500 patients within 48 hours of stroke onset.
Purpose:
- To evaluate diagnostic information from cerebrospinal fluid (CSF) in acute stroke.
- To categorize stroke patients based on CSF erythrocyte and xanthochromia findings.
- To review the role of systemic metabolic disturbances, blood-brain barrier impairment, and CNS lesions in CSF changes.
Summary:
- Patients were grouped into three types based on CSF analysis: no erythrocytes/xanthochromia (Type 1), no erythrocytes but with xanthochromia (Type 2), and presence of erythrocytes with xanthochromia (Type 3).
- Data for each CSF type were analyzed, exploring correlations with clinical findings and pathological mechanisms.
- The study discusses the implications of systemic metabolic disturbances, blood-brain barrier integrity, and central nervous system lesions on CSF composition post-stroke.
Impact:
- Provides insights into the diagnostic utility of CSF analysis in acute stroke, complementing neuroimaging.
- Highlights the relationship between CSF biomarkers and underlying stroke pathophysiology.
- Informs the clinical indications for CSF examination in stroke evaluation amidst advancements in neuroimaging.
Abstract:
In order to evaluate information on acute stroke through the study of cerebrospinal fluid (CSF) data em 1500 patients were analysed in the first 48 hours following stroke. Cases were distributed in three groups according to CSF basic findings: type 1, CSF without erythrocytes and without xanthochromia; type 2, CSF without erythrocytes and with xanthochromia; type 3, CSF with erythrocytes and with xanthochromia. Data on each type are discussed as well as correlation findings. Systemic metabolic disturbances, blood-brain barrier impairment and central nervous system lesions are discussed as to the role they have in CSF changes observed in stroke. Indication of CSF exam in stroke is reviewed taking into account progress in neuroimaging techniques.